Cargando…

Bilirubin Prevents the TH(+) Dopaminergic Neuron Loss in a Parkinson’s Disease Model by Acting on TNF-α

Parkinson’s disease (PD), the fastest-growing movement disorder, is still challenged by the unavailability of disease-modifying therapy. Mildly elevated levels of unconjugated bilirubin (UCB, PubChem CID 5280352) have been shown to be protective against several extra-CNS diseases, and the effect is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jayanti, Sri, Moretti, Rita, Tiribelli, Claudio, Gazzin, Silvia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693357/ https://www.ncbi.nlm.nih.gov/pubmed/36430754 http://dx.doi.org/10.3390/ijms232214276

Ejemplares similares

Bilirubin: A Promising Therapy for Parkinson’s Disease
por: Jayanti, Sri, et al.
Publicado: (2021)

Inflammation, Dopaminergic Brain and Bilirubin
por: Jayanti, Sri, et al.
Publicado: (2023)

The Role of Bilirubin and the Other “Yellow Players” in Neurodegenerative Diseases
por: Jayanti, Sri, et al.
Publicado: (2020)

Bilirubin and Redox Stress in Age-Related Brain Diseases
por: Llido, John Paul, et al.
Publicado: (2023)

Earliest Mechanisms of Dopaminergic Neurons Sufferance in a Novel Slow Progressing Ex Vivo Model of Parkinson Disease in Rat Organotypic Cultures of Substantia Nigra
por: Dal Ben, Matteo, et al.
Publicado: (2019)

Transport and Metabolism at Blood–Brain Interfaces and in Neural Cells: Relevance to Bilirubin-Induced Encephalopathy
por: Gazzin, Silvia, et al.
Publicado: (2012)

Curcumin Prevents Cerebellar Hypoplasia and Restores the Behavior in Hyperbilirubinemic Gunn Rat by a Pleiotropic Effect on the Molecular Effectors of Brain Damage
por: Gazzin, Silvia, et al.
Publicado: (2020)

Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment
por: Dal Ben, Matteo, et al.
Publicado: (2017)

Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia
por: Llido, John Paul, et al.
Publicado: (2023)

The Biological Effects of Bilirubin Photoisomers
por: Jasprova, Jana, et al.
Publicado: (2016)

Bilirubin-Induced Oxidative Stress Leads to DNA Damage in the Cerebellum of Hyperbilirubinemic Neonatal Mice and Activates DNA Double-Strand Break Repair Pathways in Human Cells
por: Rawat, Vipin, et al.
Publicado: (2018)

Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat
por: Vianello, Eleonora, et al.
Publicado: (2018)

Management of restless legs syndrome in chronic liver disease: A challenge for the correct diagnosis and therapy
por: Moretti, Rita, et al.
Publicado: (2018)

Homocysteine in Neurology: A Possible Contributing Factor to Small Vessel Disease
por: Moretti, Rita, et al.
Publicado: (2021)

Hepatitis C-related cryoglobulinemic neuropathy: potential role of oxcarbazepine for pain control
por: Moretti, Rita, et al.
Publicado: (2018)

Nonalcoholic Fatty Liver Disease and Altered Neuropsychological Functions in Patients with Subcortical Vascular Dementia
por: Moretti, Rita, et al.
Publicado: (2022)

Neuro-inflammatory effects of photodegradative products of bilirubin
por: Jašprová, J., et al.
Publicado: (2018)

Bilirubin 2022: The Past, the Present and the Future
por: Bellarosa, Cristina, et al.
Publicado: (2022)

Vitamin D, Homocysteine, and Folate in Subcortical Vascular Dementia and Alzheimer Dementia
por: Moretti, Rita, et al.
Publicado: (2017)

A Hypothesis for Using Pathway Genetic Load Analysis for Understanding Complex Outcomes in Bilirubin Encephalopathy
por: Riordan, Sean M., et al.
Publicado: (2016)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat
por: Gazzin, Silvia, et al.
Publicado: (2011)

Celiac Disease and Neurological Manifestations: From Gluten to Neuroinflammation
por: Giuffrè, Mauro, et al.
Publicado: (2022)

Loss of Drosha underlies dopaminergic neuron toxicity in models of Parkinson’s disease
por: Wang, Ronglin, et al.
Publicado: (2018)

Translational Approach to the Protective Effect of Bilirubin in Diabetic Kidney Disease
por: Bianco, Annalisa, et al.
Publicado: (2022)

Parkinson’s Disease, the Dopaminergic Neuron and Gammahydroxybutyrate
por: Mamelak, Mortimer
Publicado: (2018)

Molecular Imaging of Striatal Dopaminergic Neuronal Loss and the Neurovascular Unit in Parkinson Disease
por: Ivanidze, Jana, et al.
Publicado: (2020)

Long-term hyperglycemia aggravates α-synuclein aggregation and dopaminergic neuronal loss in a Parkinson’s disease mouse model
por: Lv, Yi-Qing, et al.
Publicado: (2022)

Heptachlor induced nigral dopaminergic neuronal loss and Parkinsonism-like movement deficits in mice
por: Hong, Seokheon, et al.
Publicado: (2014)

Galangin Reduces the Loss of Dopaminergic Neurons in an LPS-Evoked Model of Parkinson’s Disease in Rats
por: Chen, Guangxin, et al.
Publicado: (2017)

NXP031 prevents dopaminergic neuronal loss and oxidative damage in the AAV-WT-α-synuclein mouse model of Parkinson’s disease
por: Song, Min Kyung, et al.
Publicado: (2022)

Neonatal hyperbilirubinemia
por: Ben, Matteo Dal, et al.
Publicado: (2014)

Nitrated α-Synuclein Induces the Loss of Dopaminergic Neurons in the Substantia Nigra of Rats
por: Yu, Zhongwang, et al.
Publicado: (2010)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease
por: Kim, Ji Hwan, et al.
Publicado: (2023)

Vulnerability of Mesostriatal Dopaminergic Neurons in Parkinson's Disease
por: González-Hernández, Tomás, et al.
Publicado: (2010)

Life-Long Hyperbilirubinemia Exposure and Bilirubin Priming Prevent In Vitro Metabolic Damage
por: Bianco, Annalisa, et al.
Publicado: (2021)

Neuronal haemoglobin induces loss of dopaminergic neurons in mouse Substantia nigra, cognitive deficits and cleavage of endogenous α-synuclein
por: Santulli, Chiara, et al.
Publicado: (2022)

Treadmill exercise alleviates nigrostriatal dopaminergic loss of neurons and fibers in rotenone-induced Parkinson rats
por: Shin, Mal-Soon, et al.
Publicado: (2017)

Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
por: Benkert, Julia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kghbqe81hrgnq879fmq7inathv